SC Filed 2018-03-05 Event — SEC 0001072613-18-000184 →

Growth Equity Opportunities IV, LLC → ARCA biopharma, Inc. ORKA

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

20 transactions

0 buys · 13 sales · 5 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

10 filings by this filer

9 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 6.24

8,833,223 shares short · -3.6% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-15	Goncalves Joana	officer	Option exercise	3,500	$6.84	$24K
2026-07-15	Goncalves Joana	officer	Option exercise	3,500	$7.80	$27K
2026-07-15	Goncalves Joana	officer	Sale	400	$84.36	$34K
2026-07-15	Goncalves Joana	officer	Sale	2,497	$85.86	$214K
2026-07-15	Goncalves Joana	officer	Sale	3,803	$86.68	$330K
2026-07-15	Goncalves Joana	officer	Sale	300	$87.25	$26K
2026-07-01	Sandler Laura Lee	officer	Option exercise	5,000	$7.80	$39K
2026-07-01	Sandler Laura Lee	officer	Sale	2,237	$93.85	$210K
2026-07-01	Sandler Laura Lee	officer	Sale	2,263	$94.75	$214K
2026-07-01	Sandler Laura Lee	officer	Sale	500	$95.47	$48K
2026-07-01	Fairmount Funds Management LLC	director, 10%+ owner	C	3,553,410	—	—
2026-07-01	Fairmount Funds Management LLC	director, 10%+ owner	Sale	3,553,410	$84.43	$300.01M
2026-07-01	Fairmount Funds Management LLC	director, 10%+ owner	C	42,641	—	—
2026-06-22	Agarwal Arjun	officer	Sale	888	$80.01	$71K
2026-06-22	Agarwal Arjun	officer	Sale	699	$82.14	$57K
2026-04-15	Goncalves Joana	officer	Option exercise	3,500	$6.84	$24K
2026-04-15	Goncalves Joana	officer	Option exercise	3,500	$7.80	$27K
2026-04-15	Goncalves Joana	officer	Sale	4,227	$65.73	$278K
2026-04-15	Goncalves Joana	officer	Sale	2,273	$66.56	$151K
2026-04-15	Goncalves Joana	officer	Sale	500	$67.38	$34K

Other 13D/G Filings on ARCA biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-01	SCHEDULE 13D/A	Fairmount Funds Management LLC	19.50%	14,553,895	view →
2025-03-10	SCHEDULE	Fairmount Funds Management LLC	19.99%	8,511,824	view →
2022-07-08	SC	Funicular Funds, LP	—	—	view →
2022-04-14	SC	Funicular Fund, LP	—	—	view →
2022-04-04	SC	Funicular Fund, LP	—	—	view →
2018-01-04	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by Growth Equity Opportunities IV, LLC

Filed	Form	Issuer	Stake	Shares
2025-01-21	SCHEDULE	Verona Pharma plc	4.99%	32,679,649	view →
2022-11-28	SC	Addex Therapeutics Ltd. ADXN	—	—	view →
2022-01-10	SC	Addex Therapeutics Ltd. ADXN	—	—	view →
2021-04-21	SC	Affimed N.V.	—	—	view →
2020-08-03	SC	Verona Pharma plc	—	—	view →
2020-06-24	SC	AVEO PHARMACEUTICALS, INC.	—	—	view →
2019-04-17	SC	AVEO PHARMACEUTICALS INC	—	—	view →
2018-07-10	SC	AVEO PHARMACEUTICALS INC	—	—	view →
2018-03-19	SC	Cascadian Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →